263 related articles for article (PubMed ID: 22012825)
1. Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application.
Okano M; Sato M; Kaneko E; Kageyama S
Drug Test Anal; 2011; 3(11-12):798-805. PubMed ID: 22012825
[TBL] [Abstract][Full Text] [Related]
2. Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE.
Desharnais P; Naud JF; Ayotte C
Drug Test Anal; 2013; 5(11-12):870-6. PubMed ID: 23720238
[TBL] [Abstract][Full Text] [Related]
3. SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control.
Reichel C; Kulovics R; Jordan V; Watzinger M; Geisendorfer T
Drug Test Anal; 2009 Jan; 1(1):43-50. PubMed ID: 20355158
[TBL] [Abstract][Full Text] [Related]
4. Detection of recombinant erythropoietin biosimilar Jimaixin™ after administration in healthy subjects.
Martin L; Kafi R; Zhou X; Zhang L; Ericsson M; Marchand A
Drug Test Anal; 2022 Jan; 14(1):72-79. PubMed ID: 34391213
[TBL] [Abstract][Full Text] [Related]
5. Practicing IEF-PAGE of EPO: the impact of detergents and sample application methods on analytical performance in doping control.
Reichel C
Drug Test Anal; 2010; 2(11-12):603-19. PubMed ID: 21204292
[TBL] [Abstract][Full Text] [Related]
6. Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parameters.
Dehnes Y; Hemmersbach P
Drug Test Anal; 2011 May; 3(5):291-9. PubMed ID: 21387570
[TBL] [Abstract][Full Text] [Related]
7. Improved detection methods significantly increase the detection window for EPO microdoses.
Martin L; Martin JA; Collot D; Hoang O; Audran M; Ericsson M; Marchand A
Drug Test Anal; 2021 Jan; 13(1):101-112. PubMed ID: 32737925
[TBL] [Abstract][Full Text] [Related]
8. Defending Dynepo detection.
Gmeiner G; Reichel C; Kulovics R; Scheiblhofer V
Drug Test Anal; 2010; 2(11-12):526-32. PubMed ID: 21204285
[TBL] [Abstract][Full Text] [Related]
9. Gel electrophoretic methods for the analysis of biosimilar pharmaceuticals using the example of recombinant erythropoietin.
Reichel C; Thevis M
Bioanalysis; 2013 Mar; 5(5):587-602. PubMed ID: 23425274
[TBL] [Abstract][Full Text] [Related]
10. Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections.
Dehnes Y; Shalina A; Myrvold L
Drug Test Anal; 2013; 5(11-12):861-9. PubMed ID: 24190107
[TBL] [Abstract][Full Text] [Related]
11. Fc-fragment removal allows the EPO-Fc fusion protein to be detected in blood samples by IEF-PAGE.
Postnikov P; Krotov G; Mesonzhnik N; Efimova Y; Rodchenkov G
Drug Test Anal; 2015; 7(11-12):999-1008. PubMed ID: 26695487
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity and specificity of detection methods for erythropoietin doping in cyclists.
Heuberger JAAC; van Eenoo P; Rotmans JI; Gal P; Stuurman FE; Post TE; Daniels JMA; Ram H; de Hon O; Burggraaf J; Cohen AF
Drug Test Anal; 2019 Sep; 11(9):1290-1301. PubMed ID: 31232530
[TBL] [Abstract][Full Text] [Related]
13. The interference of heparin on IEF-PAGE of erythropoietins.
Reichel C; Benetka E; Geisendorfer T; Scheiblhofer V; Abzieher F
Drug Test Anal; 2010; 2(11-12):568-75. PubMed ID: 21204288
[TBL] [Abstract][Full Text] [Related]
14. New insights for identification of doping with recombinant human erythropoietin micro-doses after high hydration.
Martin L; Ashenden M; Bejder J; Hoffmann M; Nordsborg N; Karstoft K; Morkeberg J; Sharpe K; Lasne F; Marchand A
Drug Test Anal; 2016 Nov; 8(11-12):1119-1130. PubMed ID: 27390252
[TBL] [Abstract][Full Text] [Related]
15. Assessing the instability of the isoelectric focusing patterns of erythropoietin in urine.
Belalcazar V; Gutiérrez Gallego R; Llop E; Segura J; Pascual JA
Electrophoresis; 2006 Nov; 27(22):4387-95. PubMed ID: 17054082
[TBL] [Abstract][Full Text] [Related]
16. Data from a microdosed recombinant human erythropoietin administration study applying the new biotinylated clone AE7A5 antibody and a further optimized sarcosyl polyacrylamide gel electrophoresis protocol.
Reichel C; Erceg D; Lorenc B; Scheiblhofer V; Farmer L; Zanitzer K; Geisendorfer T; Gmeiner G; Thevis M
Drug Test Anal; 2023 Feb; 15(2):163-172. PubMed ID: 33450134
[TBL] [Abstract][Full Text] [Related]
17. Combined immuno-purification and detection of recombinant erythropoietins and activin receptor type II-Fc fusion proteins by isoelectric focusing for application in doping control.
Martin L; Audran M; Marchand A
Drug Test Anal; 2019 Jan; 11(1):168-172. PubMed ID: 30091846
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of erythropoietin biosimilars Epotin™, Hemax® and Jimaixin™ by electrophoretic methods used for doping control analysis and specific N-glycan analysis revealed structural differences from original epoetin alfa drug Eprex®.
Capdeville P; Martin L; Cholet S; Damont A; Audran M; Ericsson M; Fenaille F; Marchand A
J Pharm Biomed Anal; 2021 Feb; 194():113750. PubMed ID: 33234415
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in doping testing for erythropoietin.
Reichel C
Anal Bioanal Chem; 2011 Aug; 401(2):463-81. PubMed ID: 21637931
[TBL] [Abstract][Full Text] [Related]
20. Easy-to-use IEF compatible immunoaffinity purification of Erythropoietin from urine retentates.
Reihlen P; Völker-Schänzer E; Majer B; Schänzer W
Drug Test Anal; 2012 Nov; 4(11):813-7. PubMed ID: 22566398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
